Heart failure severity, as determined by loop diuretic dosages, predicts the risk of developing diabetes after myocardial infarction: a nationwide cohort study.
about
Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013.Evaluation of the CHADS2 risk score on short- and long-term all-cause and cardiovascular mortality after syncope.Body mass index and risk of perioperative cardiovascular adverse events and mortality in 34,744 Danish patients undergoing hip or knee replacement.Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide studyLong-term prognostic importance of diabetes after a myocardial infarction depends on left ventricular systolic functionEffect of Chronic Kidney Diseases on Mortality among Digoxin Users Treated for Non-Valvular Atrial Fibrillation: A Nationwide Register-Based Retrospective Cohort Study.Risk of Ischemic Stroke, Hemorrhagic Stroke, Bleeding, and Death in Patients Switching from Vitamin K Antagonist to Dabigatran after an Ablation.Low-density-lipoprotein cholesterol concentrations and risk of incident diabetes: epidemiological and genetic insights from the Framingham Heart Study.Short-term mortality risk of serum potassium levels in acute heart failure following myocardial infarctionPsoriasis and new-onset diabetes: a Danish nationwide cohort studyCardiogenic diabetes.Reframing the association and significance of co-morbidities in heart failure.Co-Morbidities and Cardiac Resynchronization Therapy: When Should They Modify Patient Selection?Adherence with oral anticoagulation in non-valvular atrial fibrillation: a comparison of vitamin K antagonists and non-vitamin K antagonists.Noncardiac surgery in patients with aortic stenosis: a contemporary study on outcomes in a matched sample from the Danish health care system.B-type natriuretic peptide (BNP) affects the initial response to intravenous glucose: a randomised placebo-controlled cross-over study in healthy men.Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes.Cardiovascular endocrinology: First-time heart failure increases risk of diabetes mellitus.Use of quinine and mortality-risk in patients with heart failure--a Danish nationwide observational study.Mechanical circulatory support improves diabetic control in patients with advanced heart failure.Shifting to a non-vitamin K antagonist oral anticoagulation agent from vitamin K antagonist in atrial fibrillation.The impact of co-morbidity burden on appropriate implantable cardioverter defibrillator therapy and all-cause mortality: insight from Danish nationwide clinical registers.Danish trends in pharmacotherapy, comorbidities, and demographics in patients referred for coronary angiography: what changed during a decade?Association of heart failure severity with risk of diabetes: a Danish nationwide cohort study.Optimisation of glycaemic control during episodes of severe/acute hyperglycaemia in patients with type 2 diabetes mellitus.A risk score for predicting 30-day mortality in heart failure patients undergoing non-cardiac surgery
P2860
Q30853679-73A178DC-96E8-424F-850E-6DF6C30322A7Q33162429-8919AD59-1543-4395-811D-EA20DCBC533AQ34185318-04C84B46-A5B0-47EB-9C94-830D0E164C12Q34343069-3117E6C7-5C13-4B0C-9A68-7A1C6002BE17Q35123475-BA45DB5A-C3BA-481D-BB6E-9F27332C883EQ36088648-1A46D495-D8FD-4D2D-B752-ED58430CCE13Q36113146-FD54F2FB-387F-4FC7-B81A-7452D7D475EDQ36245202-38BCB65D-4A22-4181-98A5-60870205CDAFQ36988862-58821C78-096D-4701-A06E-C51D1C803C95Q37022693-3BF462DE-8AD0-46FD-9119-06BFE82B35B4Q38156709-681BA870-91BA-4A89-8A3E-1C601C15980BQ38881287-B715CF34-BAE7-4C10-A284-18C13C3DCBE9Q39037093-9E017886-511C-423B-AEC7-D6F6A6236E6BQ40351360-B7C9CEE1-20BE-4421-9CFE-13D41C4AE9A5Q41959685-716336CA-83BC-4823-B0DB-32B295738A91Q42628315-4816DCE8-A0CE-450A-A035-78CDB9FBB7E1Q43729526-2B2F90AC-8905-4031-9B71-8DCF2A46CF4DQ43929425-D9160B08-1B69-4C0E-AD1F-CBA6252EB5A2Q44134897-CE461CF6-B614-449A-BDAB-40E34D1DCED2Q45232893-12271D3D-3A84-4F1B-AC06-585B8B2FE909Q47713452-72E8B23C-E1E9-4B2A-857C-4A5227A92C8EQ47863626-F656DE22-3C6B-4FD9-91B3-83725259737EQ48021754-8B5CD857-FC7D-4557-9413-71A1B05D0082Q50561592-9E5430C3-8025-4F78-9E15-39CD4CB35B8FQ50921668-63A4D5C3-D2EF-4524-92D5-45E7BC2649C4Q57260302-9B21E527-6386-472D-8495-DD5644AFE0D2
P2860
Heart failure severity, as determined by loop diuretic dosages, predicts the risk of developing diabetes after myocardial infarction: a nationwide cohort study.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Heart failure severity, as det ...... on: a nationwide cohort study.
@en
Heart failure severity, as det ...... on: a nationwide cohort study.
@nl
type
label
Heart failure severity, as det ...... on: a nationwide cohort study.
@en
Heart failure severity, as det ...... on: a nationwide cohort study.
@nl
prefLabel
Heart failure severity, as det ...... on: a nationwide cohort study.
@en
Heart failure severity, as det ...... on: a nationwide cohort study.
@nl
P2093
P2860
P50
P356
P1476
Heart failure severity, as det ...... on: a nationwide cohort study.
@en
P2093
Allan Vaag
Casper H Jørgensen
Charlotte Andersson
Emil L Fosbøl
Jakob Raunsø
Mette L Norgaard
Michelle Schmiegelow
Peter Weeke
P2860
P304
P356
10.1093/EURJHF/HFQ160
P577
2010-09-23T00:00:00Z